Financial Network Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$969K Sell
3,850
-102
-3% -$21.9K 0.98% 17
2026
Q1
$860K Sell
3,952
-19
-0.5% -$4.21K 0.88% 19
2025
Q4
$907K Sell
3,971
-107
-3% -$24.4K 0.95% 16
2025
Q3
$944K Buy
4,078
+25
+0.6% +$5.09K 1.03% 16
2025
Q2
$752K Buy
4,053
+8
+0.2% +$1.49K 0.91% 17
2025
Q1
$848K Buy
4,045
+896
+28% +$174K 1.11% 16
2024
Q4
$560K Sell
3,149
-1,046
-25% -$192K 1.04% 14
2024
Q3
$828K Sell
4,195
-90
-2% -$16.8K 0.68% 34
2024
Q2
$736K Buy
4,285
+100
+2% +$16.6K 0.55% 40
2024
Q1
$762K Sell
4,185
-81
-2% -$14K 0.76% 40
2023
Q4
$661K Buy
+4,266
New +$622K 0.7% 35

Other funds holding ABBV

Financial Network Wealth Advisors's ABBV Position: Q2 2026 in Review

Financial Network Wealth Advisors reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $21.9K and leaving 3,850 shares worth $969K. The position accounts for 0.98% of the portfolio, ranked #17.

Financial Network Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Financial Network Wealth Advisors held 3,850 shares of AbbVie worth $969K as of Q2 2026.
  • Financial Network Wealth Advisors sold 102 AbbVie shares in Q2 2026, an estimated $21.9K.
  • AbbVie made up 0.98% of Financial Network Wealth Advisors's portfolio in Q2 2026, its #17 holding.
  • Financial Network Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.